Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chyatte, D.
Right arrow Articles by Lewis, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chyatte, D.
Right arrow Articles by Lewis, I.

(Stroke. 1997;28:799-804.)
© 1997 American Heart Association, Inc.


Articles

Gelatinase Activity and the Occurrence of Cerebral Aneurysms

Douglas Chyatte, MD Isabel Lewis, BS

From the Cerebrovascular Research Laboratory, Section of Cerebrovascular Surgery, The Cleveland Clinic Foundation (Ohio).

Correspondence to Douglas Chyatte, MD, Section of Cerebrovascular Surgery, S80, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195. E-mail chyattd{at}cesmtp.ccf.org

Background and Purpose Cerebral aneurysms are associated with decreased arterial collagen content; however, whether this deficiency results from impaired collagen synthesis or enhanced collagen degradation is unknown. This study tested the hypothesis that enhanced collagen degradation, not impaired collagen synthesis, is associated with the occurrence of cerebral aneurysms.

Methods Cultured skin fibroblasts and serum samples were studied in patients with angiographic evidence of aneurysm (n=31) and control subjects (n=14). Transcription of the type III collagen gene was assessed with the use of Northern blots prepared from RNA harvested from confluent cultured fibroblasts. Translation of type III collagen was assessed by Western blot analysis of proteins produced by cultured skin fibroblasts. Collagen metabolism was assessed by radioimmunoassay for type I (PICP) and type III (PIIINP) procollagen peptides in conditioned tissue culture media and serum. We assessed collagen degradation in serum and conditioned tissue culture media by evaluating gelatinase activity using quantitative zymography.

Results Type III collagen synthesis was the same in aneurysm and control patients. Neither the molecular weight nor the relative amount of type III collagen mRNA differed between aneurysm and control patient fibroblasts. Western blot analysis revealed no difference in the relative amount or molecular weight of procollagen III synthesized by aneurysm and control cells. Aneurysm patients had a threefold increase in native serum gelatinase activity compared with control subjects (P=.004). This increase occurred along with serum evidence of increased collagen metabolism. Serum levels of PICP (P=.03) and PIIINP (P=.02) were decreased in aneurysm patients. Elevated serum gelatinase activity and altered collagen metabolism could not be explained by enhanced secretion of gelatinase by cultured fibroblasts or altered net collagen synthesis by fibroblasts. High serum gelatinase activity was more common in men than in women (P=.04).

Conclusions These findings are consistent with the hypothesis that accelerated enzymatic degradation of collagens and other structural proteins compromises the mechanical integrity of the cerebral vessel wall and leads to conditions that favor aneurysm formation.


Key Words: cerebral aneurysm • collagen • gelatinases • subarachnoid hemorrhage




This article has been cited by other articles:


Home page
CirculationHome page
H. Ohkuma, S. Suzuki, S. Fujita, and W. Nakamura
Role of a Decreased Expression of the Local Renin-Angiotensin System in the Etiology of Cerebral Aneurysms
Circulation, August 19, 2003; 108(7): 785 - 787.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
T. Hashimoto, G. Wen, M. T. Lawton, N. J. Boudreau, A. W. Bollen, G.-Y. Yang, N. M. Barbaro, R. T. Higashida, C. F. Dowd, V. V. Halbach, et al.
Abnormal Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Brain Arteriovenous Malformations * Growth and Bleeding in BAVM: Another Role for MMPs
Stroke, April 1, 2003; 34(4): 925 - 931.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Krex, A. Ziegler, H. K. Schackert, and G. Schackert
Lack of Association Between Endoglin Intron 7 Insertion Polymorphism and Intracranial Aneurysms in a White Population: Evidence of Racial/Ethnic Differences
Stroke, November 1, 2001; 32(11): 2689 - 2694.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. Guillon, C. Tzourio, V. Biousse, V. Adrai, M. G. Bousser, and P. J. Touboul
Arterial wall properties in carotid artery dissection: An ultrasound study
Neurology, September 12, 2000; 55(5): 663 - 666.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. G. Peters, A. Kassam, P. L. St. Jean, H. Yonas, and R. E. Ferrell
Functional Polymorphism in the Matrix Metalloproteinase-9 Promoter as a Potential Risk Factor for Intracranial Aneurysm
Stroke, December 1, 1999; 30(12): 2612 - 2616.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. S. P. van den Berg, G. Pals, F. Arwert, R. C. M. Hennekam, K. W. Albrecht, A. Westerveld, and M. Limburg
Type III Collagen Deficiency in Saccular Intracranial Aneurysms : Defect in Gene Regulation?
Stroke, August 1, 1999; 30(8): 1628 - 1631.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. R. Todor, I. Lewis, G. Bruno, and D. Chyatte
Identification of a Serum Gelatinase Associated With the Occurrence of Cerebral Aneurysms as Pro-Matrix Metalloproteinase-2
Stroke, August 1, 1998; 29(8): 1580 - 1583.
[Abstract] [Full Text] [PDF]